Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The new topical growth hormone formula has high skin penetration and bioavailability.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Certain vitamins and their derivatives can help hair grow longer by activating specific growth signals.

Social media videos made by dermatologists significantly improved patient knowledge about hair loss.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

The Hotz-Celsus surgery successfully fixed inward-turning eyelids in cattle.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Oral minoxidil rarely causes pericardial effusion, especially at low doses.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.